Safety and efficacy of levodopa-carbidopa monotherapy in patients with advanced parkinson's disease

被引:2
|
作者
Boyd, J. T. [1 ]
Zadikoff, C. [2 ]
Benesh, J. A. [3 ]
Zamudio, J. [4 ]
Robieson, W. Z. [5 ]
Kukreja, P. [4 ]
机构
[1] Univ Vermont, Lamer Coll Med, Neurol Sci, Burlington, VT USA
[2] Northwestern Univ, Feinberg Sch Med, Neurol, Chicago, IL 60611 USA
[3] AbbVie Inc, Neurosci Dev, N Chicago, IL USA
[4] AbbVie Inc, Neurosci, N Chicago, IL USA
[5] AbbVie Inc, Stat, N Chicago, IL USA
关键词
D O I
10.1016/j.jns.2017.08.525
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
498
引用
收藏
页码:182 / 183
页数:2
相关论文
共 50 条
  • [41] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
    Valldeoriola, Francesc
    Jose Catalan, Maria
    Escamilla-Sevilla, Francisco
    Freire, Eric
    Olivares, Jesus
    Cubo, Esther
    Santos Garcia, Diego
    Calopa, Matilde
    Martinez-Martin, Pablo
    Carlos Parra, Juan
    Arroyo, Gloria
    Matias Arbelo, Jose
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [42] Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease
    Udd, Marianne
    Lyytinen, Jukka
    Eerola-Rautio, Johanna
    Kenttamies, Anu
    Lindstrom, Outi
    Kylanpaa, Leena
    Pekkonen, Eero
    BRAIN AND BEHAVIOR, 2017, 7 (07):
  • [43] Stable levodopa plasma levels with jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Nyholm, D.
    Odin, P.
    Johansson, A.
    Chatamra, K.
    Locke, C.
    Freeman, S.
    Dutta, S.
    Othman, A. A.
    MOVEMENT DISORDERS, 2012, 27 : S131 - S131
  • [44] Interim results of outpatient levodopa-carbidopa intestinal gel titration in patients with advanced Parkinson's disease
    Rodriguez, R. L.
    Lobatz, M.
    Dubow, J.
    Eaton, S.
    Hall, C. M.
    Chatamra, K.
    Benesh, J. A.
    MOVEMENT DISORDERS, 2015, 30 : S115 - S116
  • [45] Levodopa-carbidopa intrajejunal gel in advanced Parkinson disease with "on" freezing of gait
    Cossu, Giovanni
    Ricchi, Valeria
    Pilleri, Manuela
    Mancini, Francesca
    Murgia, Daniela
    Ricchieri, Gianluigi
    Mereu, Alessandra
    Melis, Maurizio
    Antonini, Angelo
    NEUROLOGICAL SCIENCES, 2015, 36 (09) : 1683 - 1686
  • [46] Randomized, Double-Blind, Double-Dummy Study of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Efficacy and Safety
    Olanow, C. W.
    Antonini, A.
    Kieburtz, K.
    Fernandez, H. H.
    Espay, A. J.
    Standaert, D. G.
    Vanagunas, A.
    Widnell, K. L.
    Freeman, S.
    Robieson, W. Z.
    Pritchett, Y.
    Chatamra, K.
    Benesh, J.
    Lenz, R. A.
    ANNALS OF NEUROLOGY, 2012, 72 : S102 - S102
  • [47] Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Zorko, Nika
    Kojovic, Maja
    Flisar, Dusan
    Pirtosek, Zvezdan
    Kramberger, Milica Gregoric
    MOVEMENT DISORDERS, 2015, 30 (10) : 1434 - 1435
  • [48] Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review
    Wirdefeldt, Karin
    Odin, Per
    Nyholm, Dag
    CNS DRUGS, 2016, 30 (05) : 381 - 404
  • [49] Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel from an Open-Label Study in Japanese, Taiwanese, and Korean Patients with Advanced Parkinson's Disease
    Murata, Miho
    Mihara, Masahito
    Hasegawa, Kazuko
    Jeon, Beomseok
    Tsai, Chon-Haw
    Yokoyama, Masayuki
    Chatamra, Krai
    Benesh, Janet
    NEUROLOGY, 2016, 86
  • [50] Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience
    Virhammar, Johan
    Nyholm, Dag
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (03) : 171 - 187